Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Health

Kiwibank director joins Evolution Healthcare as chair
News in Brief

Kiwibank director joins Evolution Healthcare as chair

Scott Pickering has been appointed chair of Evolution Healthcare and director of Fidelity Life.Evolution Healthcare is a private healthcare operator and Fidelity Life is New Zealand’s largest locally-owned life insurer.His position at Evolution Healthcare began on Monday and the...

Staff reporters 01 Jul 2024
Health and Safety Reform: Watch the road not the cones
Opinion

Jeff Sissons: Health and Safety Reform: Watch the road not the cones

This govt and the previous one have been starving the health and safety system of funding.

Jeff Sissons 19 Jun 2024
Why Americans eat a sunscreen ingredient in their pizza
Health

Why Americans eat a sunscreen ingredient in their pizza

Health concerns grow over titanium dioxide, but NZ and Australia believe it's safe.

Green Cross makes healthcare a primary objective
Opinion

Paul McBeth: Green Cross makes healthcare a primary objective

Group has the country's largest general practice enrolled patient base. 

Paul McBeth 11 Jun 2024